Montclair, NJ (PRWEB) September 1, 2009
PAINWeek 2009 is planning for its largest annual conference ever, with over 1,000 healthcare practitioners, faculty, exhibitors, nonprofit and commercial sponsors, abstract presenters, and a dozen commercially supported satellite events, to be held at the Red Rock Casino, Resort, and Spa in Las Vegas, Nevada, from Wednesday, September 9, through Saturday, September 12, 2009. This unique event, which provides over 100 CE/CME hours, is now viewed by pain management stakeholders as the "not-to-be missed" pain conference.
PAINWeek caters to healthcare professionals who treat pain, and was developed for frontline clinicians--primary care and family physicians, physician assistants, dentists, nurses, pharmacists, psychologists, physical therapists, and other practitioners. Its primary purpose is continuing medical education, offering over 100+ hours of CE/CME education on pain and pain treatments, and many other activities are planned for the 4-day conference.
This year a number of truly special sessions, tracks and topics, and highlights include:
Keynote speaker Ethan Nadelmann, JD, PhD, Executive Director of the Drug Policy Alliance, the leading organization in the U.S. promoting alternatives to the war on drugs. He believes drug use is bad, but the drug war is worse. Author of Cops Across Borders, Nadelmann is widely regarded as the most prominent proponent of drug policy reform both in the U.S. and worldwide.
Medical/Legal Assembly: former Assistant US Attorney Jennifer Bolen, JD, presents a Mock Trial: U.S. vs Pain Healthcare Clinician. Bolen and peers will present every stage of a trial in which a fictional practitioner stands accused of wrongfully prescribing scheduled drugs. This "mock trial" is all too real for prescribers afraid of government surveillance. Ms. Bolen will also conduct workshops on basic legal/regulatory issues, establishing compliance programs, and risk management protocols.
American Society of Pain Educators (ASPE) convenes its annual meeting, the Pain Educators Forum, within the greater conference. This year the society welcomes the first class of Certified Pain Educators (CPEs) and also presents the inaugural ASPE Educator of the Year Awards.
Sessions on Risk Evaluation and Mitigation Strategies (REMS). REMS is the acronym on the pharmaceutical industry's radar since the FDA suggested last year that Schedule II controlled-release opioids and methadone must have a REMS. Most healthcare professionals do not know much about this or how it may impact their clinical practice. Sessions on REMS will be led by key opinion leaders who have participated in recent FDA sessions in Washington, DC.
Pain and Chemical Dependency Assembly: a number of sessions about and around the sensitive issues of pain and chemical dependency will be offered. Additionally, the use of methadone and other opiates for the treatment of pain, and how to monitor for abuse and misuse will be addressed.
The Fibromyalgia Pain Kit, a new resource for physicians, will be the topic of a commercially supported session, jointly sponsored by Global Education Group and the National Fibromyalgia Association. This session will teach practitioners how to properly diagnose and treat their patients who have fibromyalgia using the tools provided in the pain kit. All attendees will receive complimentary Pain Kit.
In addition to these fascinating events, there are also sessions on various types of pain and pain syndromes, the latest pharmacologic treatments, educating peers about pain and pain management, and complementary and alternative methods to help patients relieve pain. In addition to the CE/CME credited sessions, attendees will also be able to visit over 40 exhibit booths, numerous commercially supported satellite events, master classes, and academic debate--all while networking with opinion leaders and peers from all over the country.
For more information visit http://www.painweek.org.
Director, Public Relations